Envigo
 
 

[Webinar on-demand] Key considerations in the safety evaluation of drugs targeting immune checkpoints

Stream the ‘Key considerations in the safety evaluation of drugs targeting immune checkpoints’ webinar today and learn:

  • What is cancer immunotherapy?
  • What are the potential challenges in the safety assessment of antibodies targeting immune system checkpoints?
  • Things to consider when designing and running your nonclinical safety programmes for immune checkpoint targets
  • How to measure immunotoxicity / immunopharmacology
  • What if your chosen therapeutic has no pharmacologically relevant non-clinical safety species?



Speakers:
Lee Coney, Chief Scientific Officer – Biologics
Mandy Horn, Supervisor - Veterinary Science, Research and Support

  

Register for our webinar on-demand!